{
    "nctId": "NCT00897728",
    "briefTitle": "Study of Tumor and Blood Samples From Women With Breast Cancer",
    "officialTitle": "Colon and Breast Cancer Diagnostics. Clinical Protocol Associated With Cancer of the Breast.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 180,
    "primaryOutcomeMeasure": "Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of infiltrating unilateral breast cancer\n\n  * No in situ disease (ductal or lobular)\n  * No invasive bilateral synchronous disease\n* Breast cancer at high risk, defined by at least 2 of the following factors:\n\n  * Hormone receptor negative (HR-)\n  * Axillary node positive\n  * Histopathologic grade III\n  * High mitotic index (as defined by the Curie Institute as \\> 20 mitoses per 10 high-power fields \\[HPF\\])\n  * Tumor size \u2265 2 cm\n  * HER2-positive (3 + IHC or FISH/ICHS positive)\n  * Triple-negative tumors (HR- and HER2-negative)\n* Initial thoracic-abdomino-pelvic and bone scans must be negative\n* Underwent initial surgery\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* Serum calcium normal (15.3 mg/dL) or normalized within 8 weeks after surgery\n* No other invasive cancer within the past 5 years\n* Not pregnant or nursing\n* No psychological, familial, social, or geographical reasons that make monitoring impossible\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}